---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-009137"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:32:07.407615+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Quoin launches Netherton NOW campaign for rare disease awareness

## Summary
- Campaign 'NETHERTON NOW' launched Feb 4, 2025 to raise awareness for Netherton Syndrome.
- 20% of babies with Netherton Syndrome estimated not to survive, per company.
- Quoin has four ongoing clinical studies evaluating QRX003 for Netherton Syndrome.
- As of Feb 4, 2025, outstanding ordinary shares (ADS) total 20,585,830.

## SEC filing metadata
- accession: 0001104659-25-009137
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465925009137/0001104659-25-009137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925009137/tm255460d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-009137
- JSON: https://secwatch.observer/filing/0001104659-25-009137.json
- Plain text: https://secwatch.observer/filing/0001104659-25-009137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.